Does Menopause Increase the Risk of Coronary Heart Disease?

  • Menno V. Huisman
Part of the Medical Science Symposia Series book series (MSSS, volume 13)


It has been a constant finding for more than a century that there is a marked sex difference in risk of coronary heart disease (CHD). There is however little understanding in explaining the basis of this difference. The often-held assumption of the ovarian estrogen as a principal endogenous cardioprotective factor to explain this difference has been based on the finding of a decline in the ratio of male-to-female deaths from CHD that begins in the fifth decade. This decline in the male/female ratio is thought to be related to an increase in mortality among women following the menopause. If this were true an increase in the rate of female mortality rates should be visible following the age at which the menopause usually occurs. This chapter reviews both epidemiologic studies, which had as its objective to find evidence for this increase, and mechanistic studies.


Coronary Heart Disease Postmenopausal Woman Coronary Risk Estrogen Replacement Therapy Natural Menopause 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Furman RH. Are gonadal hormones(estrogens and androgens) of significance in the development of ischemic heart disease? Ann NY Acad Sci 1968;149:822–33.PubMedCrossRefGoogle Scholar
  2. 2.
    Tracy RC. Sex difference in coronary disease: Two opposing views. J Chron Dis 1966;19:1245–51.PubMedCrossRefGoogle Scholar
  3. 3.
    Heller RF, Jacobs HS. Coronary heart disease in relation to age, sex, and the menopause. BMJ 1978;i:472–74.Google Scholar
  4. 4.
    Tunstall-Pedoe H. Value of Dundee coronary risk-disk. BMJ 1992;305:1096.PubMedGoogle Scholar
  5. 5.
    Tunstall-Pedoe H. Viewpoint: Myth and paradox of coronary risk and the menopause. Lancet 1998;351:1425–27.PubMedCrossRefGoogle Scholar
  6. 6.
    Office of Populations Censuses and Surveys. Mortality statistics:cause 1989–1992 England and Wales. London: Her Majesty’s Stationary Office (HMSO), 1991-1993.Google Scholar
  7. 7.
    Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organisation MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583–612.PubMedGoogle Scholar
  8. 8.
    Gordon T, Kannel WB, Hjortland MC, et al. Menopause and coronary heart disease. The Framingham study. Ann Int Med 1978;89:157–61.PubMedGoogle Scholar
  9. 9.
    Stampfer MJ, Colditz GA, Willett WC. Menopause and heart disease. A review. Ann NY Acad Sci 1990;529:193–203.CrossRefGoogle Scholar
  10. 10.
    Kaufman DW, Slone D, Rosenberg L, et al. Cigarette smoking and age at natural menopause. Am J Publ Health 1980;70:420–22.CrossRefGoogle Scholar
  11. 11.
    Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26 year follow-up of the Framingham population. Am Heart J 1986;111:383–90.PubMedCrossRefGoogle Scholar
  12. 12.
    Colditz GA, Willett WC, Stampfer MJ. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–10.PubMedCrossRefGoogle Scholar
  13. 13.
    Nachtigall LE, Nachtigall RH, Nachtigall RD, et al. Estrogen replacement therapy II: A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obst Gynecol 1979;54:74–79.CrossRefGoogle Scholar
  14. 14.
    Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47–63.PubMedCrossRefGoogle Scholar
  15. 15.
    Vandenbroucke JP. Postmenopausal estrogen and cardioprotection. Editorial. Lancet 1991;337:833–34.PubMedCrossRefGoogle Scholar
  16. 16.
    Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861–67.PubMedCrossRefGoogle Scholar
  17. 17.
    Petitti D. Coronary heart disease and estrogen replacement therapy: Can compliance bias explain the results of observational studies? Ann Epidemiol 1994;4:115–18.PubMedCrossRefGoogle Scholar
  18. 18.
    van der Schouw YT, van der Graaf Y, Steyerberg EW, et al. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714–18.PubMedCrossRefGoogle Scholar
  19. 19.
    Hoogerbrugge N, Zillikens MC, Jansen H, et al. Estrogen replacement decreases the level of antibodies against oxidised low-density lipoprotein in postmenopausal women with coronary heart disease. Metabolism 1998;47:1–7.CrossRefGoogle Scholar
  20. 20.
    Bass KM, Newshaffer CJ, Klag MJ, et al. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Int Med 1993;153:2209–16.CrossRefGoogle Scholar
  21. 21.
    Matthews KA, Meilahn E, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641–46.PubMedCrossRefGoogle Scholar
  22. 22.
    Lindquist O. Intra individual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: Results from a prospective population study of women in Goeteborg, Sweden. Prev Med 1980;11:162–72.CrossRefGoogle Scholar
  23. 23.
    Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma proteins. New Engl J 1991;325:1196–1204.CrossRefGoogle Scholar
  24. 24.
    Darling GM, JA Johns, Mc Cloud PI, Davies SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. New Engl J Med 1997;337:595–601.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers and Fondazione Giovanni Lorenzini 1999

Authors and Affiliations

  • Menno V. Huisman

There are no affiliations available

Personalised recommendations